Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus Vogelmeier,Gerard J. Criner,Fernando J. Martinez,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Rongchang Chen,Marc Decramer,Leonardo M. Fabbri,Peter Frith,David M.G. Halpin,M. Victorina López Varela,Masaharu Nishimura,Nicolas Roche,Roberto Rodriguez-Roisin,Don D. Sin,Dave Singh,Robert Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Alvar Agusti +21 more
TLDR
The assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation, and the concept of de‐escalation of therapy is introduced in the treatment assessment scheme.Abstract:
This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.read more
Citations
More filters
Journal ArticleDOI
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh,Alvar Agusti,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Gerard J. Criner,Peter Frith,David M.G. Halpin,MeiLan K. Han,M. Victorina López Varela,Fernando J. Martinez,Maria Montes de Oca,Alberto Papi,Ian D. Pavord,Nicolas Roche,Don D. Sin,Robert A. Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Claus Vogelmeier +20 more
TL;DR: Blood eosinophils are recommended as a biomarker to support clinical decisions regarding the use of inhaled corticosteroids in chronic obstructive pulmonary disease patients, based on recent evidence from clinical trials.
Journal ArticleDOI
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
TL;DR: The advantages of various drug delivery vehicles are discussed for better understanding of their utility in terms of current medical needs and the application of a wide range of nanomedicines is also described in the context of major chronic diseases.
Journal ArticleDOI
COPD Guidelines: A Review of the 2018 GOLD Report.
TL;DR: The salient features of the GOLD 2018 document are reviewed and commentary on features that merit further discussion are provided based on clinical experience and practice as well as literature review current as of February 2018.
Journal ArticleDOI
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
Liwen Fang,Pei Gao,H L Bao,Xun Tang,Baohua Wang,Yajing Feng,S Cong,Juan Juan,J Fan,Ke Lu,Ning Wang,Yonghua Hu,Linhong Wang +12 more
TL;DR: The estimated overall prevalence of COPD in China in 2014–15 was 13·6%, indicating that this disease has become a major public-health problem.
References
More filters
Journal ArticleDOI
Outcomes of Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the United States, 1998–2008
Divay Chandra,Jason Stamm,Brian Taylor,Rose Mary Ramos,Lewis Satterwhite,Jerry A. Krishnan,David M. Mannino,Frank C. Sciurba,Fernando Holguin +8 more
TL;DR: The use of NIPPV has increased significantly over time among patients hospitalized for acute exacerbations of COPD, whereas the need for intubation and in-hospital mortality has declined, however, the rising mortality rate in a small but expanding group of patients requiring invasive mechanical ventilation after treatment with noninvasive ventilation needs further investigation.
Journal ArticleDOI
Asthma as a Risk Factor for COPD in a Longitudinal Study
TL;DR: Physician-diagnosed asthma is significantly associated with an increased risk for CB, emphysema, and COPD.
Journal ArticleDOI
Clinical and Radiologic Disease in Smokers With Normal Spirometry
Elizabeth A. Regan,David A. Lynch,Douglas Curran-Everett,Jeffrey L. Curtis,Jeffrey L. Curtis,John H.M. Austin,Philippe Grenier,Hans-Ulrich Kauczor,William C. Bailey,Dawn L. DeMeo,Richard Casaburi,Paul J. Friedman,Edwin J R van Beek,John E. Hokanson,Russell P. Bowler,Terri H. Beaty,George R. Washko,MeiLan K. Han,Victor Kim,Song Soo Kim,Kunihiro Yagihashi,Lacey Washington,Charlene McEvoy,Clint Tanner,David M. Mannino,Barry J. Make,Edwin K. Silverman,James D. Crapo +27 more
TL;DR: Current smoking was associated with more respiratory symptoms, but former smokers had greater emphysema and gas trapping, and individuals with respiratory impairments were more likely to use respiratory medications, and the use of these medications was associatedWith worse disease.
Journal ArticleDOI
Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial
TL;DR: The use of NPPV in patients with chronic obstructive pulmonary disease and acute respiratory failure requiring ventilatory support after failure of medical treatment avoided ETI in 48% of the patients, had the same ICU mortality as conventional treatment and, at 1-year follow-up was associated with fewer patients readmitted to the hospital or requiring for long-term oxygen supplementation.
Journal ArticleDOI
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
Kenneth R. Chapman,Jonathan Burdon,Eeva Piitulainen,Robert A. Sandhaus,Niels Seersholm,James M. Stocks,Berend C. Stoel,Liping Huang,Zhenling Yao,Jonathan M. Edelman,Noel G. McElvaney +10 more
TL;DR: The RAPID study as discussed by the authors was a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial of A1PI treatment in patients with severe α1 antitrypsin deficiency.
Related Papers (5)
Standardisation of spirometry
Martin R. Miller,John L. Hankinson,Vito Brusasco,Felip Burgos,Richard Casaburi,Allan L. Coates,Robert O. Crapo,Paul L. Enright,C.P.M. van der Grinten,P. Gustafsson,R. Jensen,D.C. Johnson,Neil R. MacIntyre,Roy T. McKay,Daniel Navajas,O. F. Pedersen,Riccardo Pellegrino,Giovanni Viegi,J. Wanger +18 more
An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation
Martijn A. Spruit,Sally J Singh,Chris Garvey,Richard ZuWallack,Linda Nici,Anne E Holland,Suzanne C. Lareau,Fabio Pitta,Louise Sewell,Jo Raskin,Jean Bourbeau,Rebecca Crouch,Frits M.E. Franssen,Richard Casaburi,Jan H. Vercoulen,Ioannis Vogiatzis,Rik Gosselink,Enrico Clini,Tanja Effing,Job van der Palen,Thierry Troosters,Daisy J.A. Janssen,Eileen G. Collins,Judith Garcia-Aymerich,Dina Brooks,Bonnie Fahy,Milo A. Puhan,Martine Hoogendoorn,Rachel Garrod,Annemie M. W. J. Schols,Brian W. Carlin,Roberto P. Benzo,Mike Morgan,Andrew L. Ries,Roger S. Goldstein,Claire A. Dowson,Jan Brozek,Claudio F. Donner,Emiel F.M. Wouters +38 more